![Neil Aubuchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Aubuchon
Corporate Officer/Principal at
VIKING THERAPEUTICS, INC.
Net worth: 174 570 $ as of 2026-06-29
Profile
Neil Aubuchon is Chief Commercial Officer at Viking Therapeutics, Inc. since 2026.
Former roles include Global Marketing Lead-General Medicine at Amgen, Inc., Vice President-Global Marketing at Santen, Inc., Chief Marketing Officer at Eli Lilly Japan KK, Chief Commercial Officer at AbCellera Biologics, Inc., and Chief Marketing Officer at Eli Lilly Australia Pty Ltd. Education includes an MBA from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-09 | 4,475 ( 0% ) | 174 570 $ | 2026-06-29 |
Neil Aubuchon active positions
| Companies | Position | Start |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Corporate Officer/Principal | 2026-01-06 |
Former positions of Neil Aubuchon
| Companies | Position | End |
|---|---|---|
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Sales & Marketing | - |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Sales & Marketing | - |
| AMGEN INC. | Sales & Marketing | - |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Training of Neil Aubuchon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Health Technology |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Health Technology |
Eli Lilly Australia Pty Ltd.
Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
- Stock Market
- Insiders
- Neil Aubuchon
Choose MarketScreener 
